Robert Orlowski, Deputy Chair of Lymphoma/Myeloma, Vice Chair of MM Research, and Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared a post on X:
“Myeloma Paper of the Day:
Younger pts w/ asymptomatic monoclonal gammopathies exhibit similar biological features vs. older pts and generally low progression rates, suggesting early detection and low risk of complications with protocolized follow-up.”
Title: Characteristics and clinical course of younger patients with asymptomatic monoclonal gammopathies
Authors: Eirini Solia, Foteini Theodorakakou, Panagiotis Malandrakis, Ioannis Ntanasis-Stathopoulos, Nikolaos Kanellias, Evangelos Eleutherakis-Papaiakovou, Magdalini Migkou, Vasiliki Spiliopoulou, Ilias Katsadouros, Konstantinos Giannakas, Stavroula Giannouli, Panagiotis Tsirigotis, Asimina Papanikolaou, Despina Fotiou, Maria Gavriatopoulou, Evangelos Terpos, Meletios-Athanasios Dimopoulos, Efstathios Kastritis
You can read the Full Article on British Journal of Haematology.
You can find other articles featuring Robert Orlowski on OncoDaily.
